CSIMarket Company Name, Ticker, Customers, else..


Novartis Ag  (NYSE: NVS)
Other Ticker:  
 

Novartis Ag

NVS's Fundamental analysis



Novartis Ag's sales fell by -9.97 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 98

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.85 %

Novartis Ag's net income grew by 113.57 % in IV. Quarter 2023 year on year, above company average,

• More on NVS's Growth


Novartis Ag
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Novartis Ag PEG ratio is at 0.12 Company is currently trading with Price to Cash flow multiple of 28.38 in trailing twelve-month period.
Company
14.36
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.57.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.


• More on NVS's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 424,182
 Net Income/Employee (TTM) $ 135,036
 Receivable Turnover (TTM) 6.57
 Tangible Book Value (Per Share $) 11.19

Novartis Ag
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Novartis Ag PEG ratio is at 0.12 Company is currently trading with Price to Cash flow multiple of 28.38 in trailing twelve-month period.
Company
14.36
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.57.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.

Novartis Ag Price to Book Ratio is at 4.56 lower than Industry Avg. of 81.16. and higher than S&P 500 Avg. of 0.01

• More on NVS's Valuation

•  Market Capitalization (Millions $) 213,321
•  Shares Outstanding (Millions) 2,092
•  Employees 110,000
•  Revenues (TTM) (Millions $) 46,660
•  Net Income (TTM) (Millions $) 14,854
•  Cash Flow (TTM) (Millions $) 7,517
•  Capital Exp. (TTM) (Millions $) -1,060
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 424,182
•  Net Income/Employee(TTM) $ 135,036
•  Receivable Turnover Ratio (TTM) 6.57
•  Tangible Book Value (Per Share $) 11.19

•  Market Capitalization (Millions $) 213,321
•  Shares Outstanding (Millions) 2,092
•  Employees 110,000
•  Revenues (TTM) (Millions $) 46,660
•  Net Income (TTM) (Millions $) 14,854
•  Cash Flow (TTM) (Millions $) 7,517
•  Capital Exp. (TTM) (Millions $) -1,060


    NVS's Profitability Comparisons
Novartis Ag